The mechanisms by which DNLA improves cognitive dysfunction in animal models of AD may be related to improving the production of extracellular amyloid plaques, regulating tau protein hyperphosphorylation, inhibiting neuroinflammation and neuronal apoptosis, activating autophagy, and enhancing synaptic connections (Li D. D. et al., 2022). Here, MAPT is linked to Alzheimer disease.